Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marcin Radzik"'
Autor:
Michał Maurin, Monika Wyczółkowska, Agnieszka Sawicka, Arkadiusz Eugeniusz Sikora, Urszula Karczmarczyk, Barbara Janota, Marcin Radzik, Dominik Kłudkiewicz, Justyna Pijarowska-Kruszyna, Antoni Jaroń, Wioletta Wojdowska, Piotr Garnuszek
Publikováno v:
Molecules, Vol 27, Iss 21, p 7216 (2022)
Despite significant advances in nuclear medicine for diagnosing and treating prostate cancer (PCa), research into new ligands with increasingly better biological properties is still ongoing. Prostate-specific membrane antigen (PSMA) ligands show grea
Externí odkaz:
https://doaj.org/article/556af5e2d5bb4c0b94113b833c84ca41
Autor:
Wioletta Wojdowska, Barbara Janota, Marcin Radzik, Agnieszka Sawicka, Justyna Pijarowska-Kruszyna, Antoni Jaron, Michal Maurin, Monika Wyczólkowska, Piotr Garnuszek
Publikováno v:
Nuclear Medicine and Biology. :S146
Autor:
Marcin Radzik, Piotr Garnuszek, Renata Mikolajczak, Justyna Pijarowska-Kruszyna, Michał Maurin, Clemens Decristoforo, Antoni Jaron
Publikováno v:
Nuclear medicine and biology. 93
Introduction The information on the presence of cold metal complexes in radiolabeled DOTA-TATE or DOTA-TOC is important in assessing the cause of the radiolabeling failure, poor radiolabeling yield and/or low effective molar activity. DOTA-peptide co
Autor:
Justyna Pijarowska-Kruszyna, Piotr Garnuszek, Urszula Karczmarczyk, Antoni Jaron, Marcin Radzik, Ewa Laszuk, Renata Mikolajczak
Publikováno v:
Nuclear Medicine Review. 20:88-94
BACKGROUND: Technetium Tc99m Exametazime (99mTc-HMPAO) is currently used as a radiopharmaceutical for determining regional cerebral blood flow and for the labelling of autologous leucocytes for infection and inflammation imaging. The HMPAO ligand exi